My NCBI | Sign In
RSS Settings
  • Search: BELLDEGRUN A[au]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 354

    1.

    Comparison of accuracy of 14-, 18- and 20-G needles in ex-vivo renal mass biopsy: a prospective, blinded study.

    Breda A, Treat EG, Haft-Candell L, Leppert JT, Harper JD, Said J, Raman S, Smith RB, Belldegrun AS, Schulam PG.

    BJU Int. 2009 Nov 2. [Epub ahead of print]PMID: 19888984 [PubMed - as supplied by publisher]Related articles

    2.

    Conditional survival predictions after nephrectomy for renal cell carcinoma.

    Karakiewicz PI, Suardi N, Capitanio U, Isbarn H, Jeldres C, Perrotte P, Sun M, Ficarra V, Zigeuner R, Tostain J, Mejean A, Cindolo L, Pantuck AJ, Belldegrun AS, Zini L, de la Taille A, Chautard D, Descotes JL, Shariat SF, Valeri A, Mulders PF, Lang H, Lechevallier E, Patard JJ.

    J Urol. 2009 Dec;182(6):2607-12. Epub 2009 Oct 17.PMID: 19836798 [PubMed - in process]Related articles

    3.

    Cytoreductive nephrectomy for kidney cancer with sarcomatoid histology--is up-front resection indicated and, if not, is it avoidable?

    Shuch B, Said J, La Rochelle JC, Zhou Y, Li G, Klatte T, Kabbinaavar FF, Pantuck AJ, Belldegrun AS.

    J Urol. 2009 Nov;182(5):2164-71. Epub 2009 Sep 16.PMID: 19758641 [PubMed - indexed for MEDLINE]Related articles

    4.

    Editorial comment.

    Pouliot F, Belldegrun A.

    Urology. 2009 Sep;74(3):641-2; author reply 642. No abstract available. PMID: 19716921 [PubMed - indexed for MEDLINE]Related articles

    5.

    Guideline for management of the clinical T1 renal mass.

    Campbell SC, Novick AC, Belldegrun A, Blute ML, Chow GK, Derweesh IH, Faraday MM, Kaouk JH, Leveillee RJ, Matin SF, Russo P, Uzzo RG; Practice Guidelines Committee of the American Urological Association.

    J Urol. 2009 Oct;182(4):1271-9. Epub 2009 Aug 14. No abstract available. PMID: 19683266 [PubMed - indexed for MEDLINE]Related articles

    6.

    Best of the 2009 AUA Annual Meeting: Highlights from the 2009 Annual Meeting of the American Urological Association, April 25-30, 2009, Chicago, IL.

    Brawer MK, Loeb S, Partin AW, Yoshimura N, Chancellor MB, Roehrborn CG, Assimos DG, Nickel JC, Shuch B, Pouliot F, Belldegrun AS, Shapiro E.

    Rev Urol. 2009 Spring;11(2):82-107. No abstract available. PMID: 19680529 [PubMed - in process]Related articlesFree article

    7.

    CA9 gene: single nucleotide polymorphism predicts metastatic renal cell carcinoma prognosis.

    de Martino M, Klatte T, Seligson DB, LaRochelle J, Shuch B, Caliliw R, Li Z, Kabbinavar FF, Pantuck AJ, Belldegrun AS.

    J Urol. 2009 Aug;182(2):728-34. Epub 2009 Jun 18.PMID: 19539328 [PubMed - indexed for MEDLINE]Related articles

    8.

    Positive Surgical Margin Appears to Have Negligible Impact on Survival of Renal Cell Carcinomas Treated by Nephron-Sparing Surgery.

    Bensalah K, Pantuck AJ, Rioux-Leclercq N, Thuret R, Montorsi F, Karakiewicz PI, Mottet N, Zini L, Bertini R, Salomon L, Villers A, Soulie M, Bellec L, Rischmann P, De La Taille A, Avakian R, Crepel M, Ferriere JM, Bernhard JC, Dujardin T, Pouliot F, Rigaud J, Pfister C, Albouy B, Guy L, Joniau S, van Poppel H, Lebret T, Culty T, Saint F, Zisman A, Raz O, Lang H, Spie R, Wille A, Roigas J, Aguilera A, Rambeaud B, Piñeiro LM, Nativ O, Farfara R, Richard F, Roupret M, Doehn C, Bastian PJ, Muller SC, Tostain J, Belldegrun AS, Patard JJ.

    Eur Urol. 2009 Mar 31. [Epub ahead of print]PMID: 19359089 [PubMed - as supplied by publisher]Related articles

    9.

    Functional and oncological outcomes of partial nephrectomy of solitary kidneys.

    La Rochelle J, Shuch B, Riggs S, Liang LJ, Saadat A, Kabbinavar F, Pantuck A, Belldegrun A.

    J Urol. 2009 May;181(5):2037-42; discussion 2043. Epub 2009 Mar 18.PMID: 19298974 [PubMed - indexed for MEDLINE]Related articles

    10.

    Molecular signatures of localized clear cell renal cell carcinoma to predict disease-free survival after nephrectomy.

    Klatte T, Seligson DB, LaRochelle J, Shuch B, Said JW, Riggs SB, Zomorodian N, Kabbinavar FF, Pantuck AJ, Belldegrun AS.

    Cancer Epidemiol Biomarkers Prev. 2009 Mar;18(3):894-900. Epub 2009 Feb 24.PMID: 19240241 [PubMed - indexed for MEDLINE]Related articles

    11.

    Presence of tumor necrosis is not a significant predictor of survival in clear cell renal cell carcinoma: higher prognostic accuracy of extent based rather than presence/absence classification.

    Klatte T, Said JW, de Martino M, Larochelle J, Shuch B, Rao JY, Thomas GV, Kabbinavar FF, Belldegrun AS, Pantuck AJ.

    J Urol. 2009 Apr;181(4):1558-64; discussion 1563-4. Epub 2009 Feb 23.PMID: 19230920 [PubMed - indexed for MEDLINE]Related articles

    12.

    Cytogenetic and molecular tumor profiling for type 1 and type 2 papillary renal cell carcinoma.

    Klatte T, Pantuck AJ, Said JW, Seligson DB, Rao NP, LaRochelle JC, Shuch B, Zisman A, Kabbinavar FF, Belldegrun AS.

    Clin Cancer Res. 2009 Feb 15;15(4):1162-9.PMID: 19228721 [PubMed - indexed for MEDLINE]Related articles

    13.

    Carbonic anhydrase IX in bladder cancer: a diagnostic, prognostic, and therapeutic molecular marker.

    Klatte T, Seligson DB, Rao JY, Yu H, de Martino M, Kawaoka K, Wong SG, Belldegrun AS, Pantuck AJ.

    Cancer. 2009 Apr 1;115(7):1448-58.PMID: 19195047 [PubMed - indexed for MEDLINE]Related articles

    14.

    Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma.

    Klatte T, Rao PN, de Martino M, LaRochelle J, Shuch B, Zomorodian N, Said J, Kabbinavar FF, Belldegrun AS, Pantuck AJ.

    J Clin Oncol. 2009 Feb 10;27(5):746-53. Epub 2009 Jan 5.PMID: 19124809 [PubMed - indexed for MEDLINE]Related articles

    15.

    Intraoperative thrombus embolization during nephrectomy and tumor thrombectomy: critical analysis of the University of California-Los Angeles experience.

    Shuch B, Larochelle JC, Onyia T, Vallera C, Margulis D, Pantuck AJ, Smith RB, Belldegrun AS.

    J Urol. 2009 Feb;181(2):492-8; discussion 498-9. Epub 2008 Dec 24.PMID: 19110280 [PubMed - indexed for MEDLINE]Related articles

    16.

    Associations between variants of the 8q24 chromosome and nine smoking-related cancer sites.

    Park SL, Chang SC, Cai L, Cordon-Cardo C, Ding BG, Greenland S, Hussain SK, Jiang Q, Liu S, Lu ML, Mao JT, Morgenstern H, Mu LN, Ng LJ, Pantuck A, Rao J, Reuter VE, Tashkin DP, You NC, Yu CQ, Yu SZ, Zhao JK, Belldegrun A, Zhang ZF.

    Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):3193-202.PMID: 18990762 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Partial nephrectomy: a contemporary review regarding outcomes and different techniques.

    Riggs SB, Larochelle JC, Belldegrun AS.

    Cancer J. 2008 Sep-Oct;14(5):302-7. Review.PMID: 18836334 [PubMed - indexed for MEDLINE]Related articles

    18.

    Cancer-specific survival outcomes among patients treated during the cytokine era of kidney cancer (1989-2005): a benchmark for emerging targeted cancer therapies.

    Belldegrun AS, Klatte T, Shuch B, LaRochelle JC, Miller DC, Said JW, Riggs SB, Zomorodian N, Kabbinavar FF, Dekernion JB, Pantuck AJ.

    Cancer. 2008 Nov 1;113(9):2457-63.PMID: 18823034 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Pomegranate extract inhibits androgen-independent prostate cancer growth through a nuclear factor-kappaB-dependent mechanism.

    Rettig MB, Heber D, An J, Seeram NP, Rao JY, Liu H, Klatte T, Belldegrun A, Moro A, Henning SM, Mo D, Aronson WJ, Pantuck A.

    Mol Cancer Ther. 2008 Sep;7(9):2662-71. Erratum in: Mol Cancer Ther. 2008 Nov;7(11):3654. PMID: 18790748 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Surveillance for renal cell carcinoma: why and how? When and how often?

    Klatte T, Lam JS, Shuch B, Belldegrun AS, Pantuck AJ.

    Urol Oncol. 2008 Sep-Oct;26(5):550-4. Epub 2007 Dec 3. Review.PMID: 18774472 [PubMed - indexed for MEDLINE]Related articles

    21.

    Prognostic variables to predict cancer-related death in incidental renal tumours.

    Bensalah K, Pantuck AJ, Crepel M, Verhoest G, Méjean A, Valéri A, Ficarra V, Pfister C, Ferrière JM, Soulié M, Cindolo L, De La Taille A, Tostain J, Chautard D, Schips L, Zigeuner R, Abbou CC, Lobel B, Salomon L, Lechevallier E, Descotes JL, Guillé F, Colombel M, Belldegrun AS, Patard JJ.

    BJU Int. 2008 Nov;102(10):1376-80. Epub 2008 Aug 22.PMID: 18727618 [PubMed - indexed for MEDLINE]Related articles

    22.

    Brain metastasis from renal cell carcinoma: presentation, recurrence, and survival.

    Shuch B, La Rochelle JC, Klatte T, Riggs SB, Liu W, Kabbinavar FF, Pantuck AJ, Belldegrun AS.

    Cancer. 2008 Oct 1;113(7):1641-8.PMID: 18671240 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    The staging of renal cell carcinoma.

    Shuch B, La Rochelle JC, Pantuck AJ, Belldegrun AS.

    Curr Opin Urol. 2008 Sep;18(5):455-61. Review.PMID: 18670267 [PubMed - indexed for MEDLINE]Related articles

    24.

    Performance status and cytoreductive nephrectomy: redefining management in patients with poor performance.

    Shuch B, La Rochelle JC, Wu J, Klatte T, Riggs SB, Kabbinavar F, Belldegrun AS, Pantuck AJ.

    Cancer. 2008 Sep 15;113(6):1324-31.PMID: 18661529 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Carbonic anhydrase IX as a predictive biomarker for clear cell renal cell carcinoma.

    Pantuck AJ, Klatte T, Seligson D, Atkins M, Belldegrun A.

    J Clin Oncol. 2008 Jun 20;26(18):3105-7; author reply 3107-9. No abstract available. PMID: 18565906 [PubMed - indexed for MEDLINE]Related articles

    26.

    Re: efficacy of sunitinib and sorafenib in metastatic papillary and chromophobe renal cell carcinoma.

    Shuch B, Belldegrun A.

    Eur Urol. 2008 May;53(5):1085-6. No abstract available. PMID: 18485320 [PubMed]Related articles

    27.

    Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinoma.

    Patard JJ, Fergelot P, Karakiewicz PI, Klatte T, Trinh QD, Rioux-Leclercq N, Said JW, Belldegrun AS, Pantuck AJ.

    Int J Cancer. 2008 Jul 15;123(2):395-400.PMID: 18464292 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    The role of carbonic anhydrase IX as a molecular marker for transitional cell carcinoma of the bladder.

    Klatte T, Belldegrun AS, Pantuck AJ.

    BJU Int. 2008 Jun;101 Suppl 4:45-8. Review. No abstract available. PMID: 18430124 [PubMed - indexed for MEDLINE]Related articles

    29.

    Carbonic anhydrase IX and renal cell carcinoma: prognosis, response to systemic therapy, and future vaccine strategies.

    Shuch B, Li Z, Belldegrun AS.

    BJU Int. 2008 Jun;101 Suppl 4:25-30. Review. No abstract available. PMID: 18430119 [PubMed - indexed for MEDLINE]Related articles

    30.

    Carbonic anhydrase IX: role in diagnosis prognosis and cancer therapy. Introduction.

    Belldegrun AS, Bevan P.

    BJU Int. 2008 Jun;101 Suppl 4:1. No abstract available. PMID: 18430114 [PubMed - indexed for MEDLINE]Related articles

    31.

    Neoadjuvant targeted therapy and advanced kidney cancer: observations and implications for a new treatment paradigm.

    Shuch B, Riggs SB, LaRochelle JC, Kabbinavar FF, Avakian R, Pantuck AJ, Patard JJ, Belldegrun AS.

    BJU Int. 2008 Sep;102(6):692-6. Epub 2008 Apr 10.PMID: 18410444 [PubMed - indexed for MEDLINE]Related articles

    32.

    Pathobiology and prognosis of chromophobe renal cell carcinoma.

    Klatte T, Han KR, Said JW, Böhm M, Allhoff EP, Kabbinavar FF, Belldegrun AS, Pantuck AJ.

    Urol Oncol. 2008 Nov-Dec;26(6):604-9. Epub 2008 Jan 14.PMID: 18367104 [PubMed - indexed for MEDLINE]Related articles

    33.

    Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas.

    Klatte T, Patard JJ, de Martino M, Bensalah K, Verhoest G, de la Taille A, Abbou CC, Allhoff EP, Carrieri G, Riggs SB, Kabbinavar FF, Belldegrun AS, Pantuck AJ.

    J Urol. 2008 May;179(5):1719-26. Epub 2008 Mar 17.PMID: 18343437 [PubMed - indexed for MEDLINE]Related articles

    34.

    Dose and schedule study of panitumumab monotherapy in patients with advanced solid malignancies.

    Weiner LM, Belldegrun AS, Crawford J, Tolcher AW, Lockbaum P, Arends RH, Navale L, Amado RG, Schwab G, Figlin RA.

    Clin Cancer Res. 2008 Jan 15;14(2):502-8.PMID: 18223225 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma.

    Klatte T, Seligson DB, Riggs SB, Leppert JT, Berkman MK, Kleid MD, Yu H, Kabbinavar FF, Pantuck AJ, Belldegrun AS.

    Clin Cancer Res. 2007 Dec 15;13(24):7388-93.PMID: 18094421 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Proteomic identification of interleukin-2 therapy response in metastatic renal cell cancer.

    Jones J, Otu HH, Grall F, Spentzos D, Can H, Aivado M, Belldegrun AS, Pantuck AJ, Libermann TA.

    J Urol. 2008 Feb;179(2):730-6. Epub 2007 Dec 20.PMID: 18082202 [PubMed - indexed for MEDLINE]Related articles

    37.

    Which pathological features of renal cell carcinoma have the greatest prognostic value?

    La Rochelle J, Belldegrun AS.

    Nat Clin Pract Urol. 2008 Feb;5(2):74-5. Epub 2007 Dec 4. No abstract available. PMID: 18059390 [PubMed]Related articles

    38.

    Update on partial nephrectomy and novel techniques.

    Riggs SB, Klatte T, Belldegrun AS.

    Urol Oncol. 2007 Nov-Dec;25(6):520-2. Review.PMID: 18047964 [PubMed - indexed for MEDLINE]Related articles

    39.

    In vivo efficacy of laparoscopic assisted percutaneous renal cryotherapy: evidence based guidelines for the practicing urologist.

    Breda A, Lam JS, Riggs S, Leppert JT, Gui D, Said JW, Schulam PG, Belldegrun AS.

    J Urol. 2008 Jan;179(1):333-7. Epub 2007 Nov 19.PMID: 18006012 [PubMed - indexed for MEDLINE]Related articles

    40.

    The chemokine receptor CXCR3 is an independent prognostic factor in patients with localized clear cell renal cell carcinoma.

    Klatte T, Seligson DB, Leppert JT, Riggs SB, Yu H, Zomorodian N, Kabbinavar FF, Strieter RM, Belldegrun AS, Pantuck AJ.

    J Urol. 2008 Jan;179(1):61-6. Epub 2007 Nov 13.PMID: 17997430 [PubMed - indexed for MEDLINE]Related articles

    41.

    Cytoreductive nephron-sparing surgery does not appear to undermine disease-specific survival in patients with metastatic renal cell carcinoma.

    Hutterer GC, Patard JJ, Colombel M, Belldegrun AS, Pfister C, Guille F, Artibani W, Montorsi F, Pantuck AJ, Karakiewicz PI.

    Cancer. 2007 Dec 1;110(11):2428-33.PMID: 17941033 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    A novel resectoscope for transurethral resection of bladder tumors and the prostate.

    Pantuck AJ, Baniel J, Kirkali Z, Klatte T, Zomorodian N, Yossepowitch O, Belldegrun AS.

    J Urol. 2007 Dec;178(6):2331-6; discussion 2336. Epub 2007 Oct 22.PMID: 17936809 [PubMed - indexed for MEDLINE]Related articles

    43.

    Unclassified renal cell carcinoma: an analysis of 85 cases.

    Karakiewicz PI, Hutterer GC, Trinh QD, Pantuck AJ, Klatte T, Lam JS, Guille F, de La Taille A, Novara G, Tostain J, Cindolo L, Ficarra V, Schips L, Zigeuner R, Mulders PF, Chautard D, Lechevallier E, Valeri A, Descotes JL, Lang H, Soulie M, Ferriere JM, Pfister C, Mejean A, Belldegrun AS, Patard JJ.

    BJU Int. 2007 Oct;100(4):802-8.PMID: 17822461 [PubMed - indexed for MEDLINE]Related articles

    44.

    Pomegranate ellagitannin-derived metabolites inhibit prostate cancer growth and localize to the mouse prostate gland.

    Seeram NP, Aronson WJ, Zhang Y, Henning SM, Moro A, Lee RP, Sartippour M, Harris DM, Rettig M, Suchard MA, Pantuck AJ, Belldegrun A, Heber D.

    J Agric Food Chem. 2007 Sep 19;55(19):7732-7. Epub 2007 Aug 28.PMID: 17722872 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    Prognostic factors for renal cell carcinoma with tumor thrombus extension.

    Klatte T, Pantuck AJ, Riggs SB, Kleid MD, Shuch B, Zomorodian N, Kabbinavar FF, Belldegrun AS.

    J Urol. 2007 Oct;178(4 Pt 1):1189-95; discussion 1195. Epub 2007 Aug 14.PMID: 17698087 [PubMed - indexed for MEDLINE]Related articles

    46.

    Differential diagnosis of hypercalcemia in renal malignancy.

    Klatte T, Said JW, Belldegrun AS, Pantuck AJ.

    Urology. 2007 Jul;70(1):179.e7-8.PMID: 17656242 [PubMed - indexed for MEDLINE]Related articles

    47.

    Understanding the natural biology of kidney cancer: implications for targeted cancer therapy.

    Klatte T, Pantuck AJ, Kleid MD, Belldegrun AS.

    Rev Urol. 2007 Spring;9(2):47-56.PMID: 17592537 [PubMed - in process]Related articlesFree article

    48.

    Prognostic impact of tumor size on pT2 renal cell carcinoma: an international multicenter experience.

    Klatte T, Patard JJ, Goel RH, Kleid MD, Guille F, Lobel B, Abbou CC, De La Taille A, Tostain J, Cindolo L, Altieri V, Ficarra V, Artibani W, Prayer-Galetti T, Allhoff EP, Schips L, Zigeuner R, Figlin RA, Kabbinavar FF, Pantuck AJ, Belldegrun AS, Lam JS.

    J Urol. 2007 Jul;178(1):35-40; discussion 40. Epub 2007 May 22.PMID: 17521678 [PubMed - indexed for MEDLINE]Related articles

    49.

    Metachronous bilateral renal cell carcinoma: risk assessment, prognosis and relevance of the primary-free interval.

    Klatte T, Patard JJ, Wunderlich H, Goel RH, Lam JS, Junker K, Schubert J, Böhm M, Allhoff EP, Kabbinavar FF, Crepel M, Cindolo L, De La Taille A, Tostain J, Mejean A, Soulie M, Bellec L, Bernhard JC, Ferriere JM, Pfister C, Albouy B, Colombel M, Zisman A, Belldegrun AS, Pantuck AJ.

    J Urol. 2007 Jun;177(6):2081-6; discussion 2086-7.PMID: 17509291 [PubMed - indexed for MEDLINE]Related articles

    50.

    Expression of CXCR3 on mononuclear cells and CXCR3 ligands in patients with metastatic renal cell carcinoma in response to systemic IL-2 therapy.

    Reckamp KL, Figlin RA, Moldawer N, Pantuck AJ, Belldegrun AS, Burdick MD, Strieter RM.

    J Immunother. 2007 May-Jun;30(4):417-24.PMID: 17457216 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    31 free full-text articles in PubMed Central

    Find related data

    Search details

    » See more...

    Recent activity